We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.6B
1-Year Est. Return 109.28%
This Fund
S&P 500
This Quarter Est. Return
+24.06%
1 Year Est. Return
+109.28%
3 Year Est. Return
+327.77%
5 Year Est. Return
+375.26%
10 Year Est. Return
+1,905.03%
AUM
$7.6B
AUM Growth
-$114M
Cap. Flow
+$280M
Cap. Flow %
3.68%
Top 10 Hldgs %
17.53%
Holding
2,785
New
772
Increased
622
Reduced
585
Closed
586

Top Buys

Rank Stock Value
1
AMT icon
American Tower
AMT
+$51.2M
2
BP icon
BP
BP
+$43.3M
3
DLR icon
Digital Realty Trust
DLR
+$31.4M
4
MMM icon
3M
MMM
+$27.6M
5
SHEL icon
Shell
SHEL
+$26.5M

Top Sells

Rank Stock Value
1
STX icon
Seagate
STX
+$38.9M
2
MU icon
Micron Technology
MU
+$28.3M
3
GE icon
GE Aerospace
GE
+$27.8M
4
TERN
Terns Pharmaceuticals
TERN
+$25.6M
5
MLYS icon
Mineralys Therapeutics
MLYS
+$23.4M

Sector Composition

Rank Sector Weight
1 Miscellaneous 35.54%
2 Healthcare 11.95%
3 Technology 11.57%
4 Industrials 8.74%
5 Consumer Discretionary 7.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DMIIR
2151
Drugs Made In America Acquisition II Corp Right
DMIIR
$20.4K ﹤0.01%
255,536
-13,666
-5% -$1.17K
ALISR
2152
Calisa Acquisition Corp Right
ALISR
$19.7K ﹤0.01%
26,950
-550
-2% -$338
NYXH
2153
Nyxoah
NYXH
$148M
$19.4K ﹤0.01%
11,474
– –
AXINR
2154
Axiom Intelligence Acquisition Corp 1 Right
AXINR
$18.8K ﹤0.01%
50,000
-25,000
-33% -$8.37K
HAVAR
2155
Harvard Ave Acquisition Corp Rights
HAVAR
$18.8K ﹤0.01%
136,590
– –
ONFOW icon
2156
Onfolio Holdings Warrant
ONFOW
$88.9K
$17.4K ﹤0.01%
60,000
– –
RIBBR
2157
Ribbon Acquisition Corp Rights
RIBBR
$17.1K ﹤0.01%
69,819
– –
NEXRW
2158
Nexera Technologies Ltd Warrant
NEXRW
$16.2K ﹤0.01%
24,038
– –
QUMSR
2159
Quantumsphere Acquisition Corp Rights
QUMSR
$16.1K ﹤0.01%
100,000
– –
CNDT icon
2160
Conduent
CNDT
$255M
$16.1K ﹤0.01%
11,000
– –
FGMCR
2161
DELISTED
FG Merger II Corp Rights
FGMCR
$15.8K ﹤0.01%
17,511
-111,384
-86% -$79.4K
REI icon
2162
Ring Energy
REI
$354M
$15.7K ﹤0.01%
14,522
-96,416
-87% -$134K
DRMAW
2163
DELISTED
Dermata Therapeutics Warrant
DRMAW
$15.5K ﹤0.01%
12,000
– –
NMPAR
2164
NMP Acquisition Corp Right
NMPAR
$14.8K ﹤0.01%
75,000
– –
MGRX icon
2165
Mangoceuticals
MGRX
$10.1M
$14.6K ﹤0.01%
38,441
– –
QETAR icon
2166
Quetta Acquisition Corp Right
QETAR
$13.9K ﹤0.01%
18,068
-680
-4% -$607
RMSGW
2167
Real Messenger Corp Warrants
RMSGW
$13.7K ﹤0.01%
28,006
-460,494
-94% -$23.8K
LCTX icon
2168
Lineage Cell Therapeutics
LCTX
$260M
$13.1K ﹤0.01%
10,000
– –
RFAMR
2169
RF Acquisition Corp III Rights
RFAMR
$13.1K ﹤0.01%
108,896
– –
VECA.RT
2170
Vernal Capital Acquisition Corp Rights
VECA.RT
$12.8K ﹤0.01%
+57,981
New +$13.2K
TWLVR
2171
Twelve Seas Investment Co III Rights
TWLVR
$11.6K ﹤0.01%
75,000
– –
TRGSR
2172
TRG Latin America Acquisitions Corp Rights
TRGSR
$10.6K ﹤0.01%
+58,950
New +$12K
LCCCR
2173
Lakeshore Acquisition III Corp Rights
LCCCR
$10.3K ﹤0.01%
51,300
– –
IPEXR
2174
Inflection Point Acquisition Corp V Rights
IPEXR
$10.1K ﹤0.01%
14,686
– –
CHARR
2175
Charlton Aria Acquisition Corp Rights
CHARR
$10.1K ﹤0.01%
105,890
– –
85 86
87
88 89

Similar funds

CCWA
CLA (CliftonLarsonAllen) Wealth Advisors Minneapolis, Minnesota $7.61B AUM 16.44% 1-Year Est. Return
CIA
Capital Investment Advisors Atlanta, Georgia $7.59B AUM 23.38% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $7.59B AUM 23.44% 1-Year Est. Return
SCB
Saudi Central Bank Riyadh, Saudi Arabia $7.63B AUM 53.44% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return
RIG
RiverFront Investment Group Richmond, Virginia $7.56B AUM 23.82% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $7.65B AUM 13.86% 1-Year Est. Return

Boothbay Fund Management's Q2 2026 Portfolio in Review

As of Q2 2026, Boothbay Fund Management held 2,785 positions worth $7.6B, down 1.5% from $7.71B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Boothbay Fund Management deployed $280M of net new capital in Q2 2026, opening 772 new positions and adding to 622 existing holdings. Its largest new stake was BP: 986,363 shares worth $36.4M.

By sector, the portfolio is most concentrated in Miscellaneous at 36% of assets, down from 48% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Seagate, an estimated $38.9M trimmed.

  • Boothbay Fund Management's largest Q2 2026 buy was BP: 986,363 shares worth $36.4M.
  • Boothbay Fund Management added most to American Tower in Q2 2026, an estimated $51.2M increase.
  • Boothbay Fund Management's biggest Q2 2026 reduction was Seagate, cutting an estimated $38.9M.
  • Boothbay Fund Management fully exited Terns Pharmaceuticals in Q2 2026, selling an estimated $25.6M.
  • Boothbay Fund Management's ten largest holdings make up 18% of its $7.6B portfolio in Q2 2026.
  • Boothbay Fund Management opened 772 new positions and closed 586 in Q2 2026.
  • Boothbay Fund Management's portfolio value fell 1.5% quarter-over-quarter to $7.6B.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.